Evidence for single-dose protection by the bivalent HPV vaccine—Review of the Costa Rica HPV vaccine trial and future research studies

The Costa Rica Vaccine Trial (CVT), a phase III randomized clinical trial, provided the initial data that one dose of the HPV vaccine could provide durable protection against HPV infection. Although the study design was to administer all participants three doses of HPV or control vaccine, 20% of wom...

Descripción completa

Detalles Bibliográficos
Autores principales: Kreimer, Aimée R., Herrero, Rolando, Sampson, Joshua N., Porras, Carolina, Lowy, Douglas R., Schiller, John T., Schiffman, Mark, Rodriguez, Ana Cecilia, Chanock, Stephen, Jimenez, Silvia, Schussler, John, Gail, Mitchell H., Safaeian, Mahboobeh, Kemp, Troy J., Cortes, Bernal, Pinto, Ligia A., Hildesheim, Allan, Gonzalez, Paula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054558/
https://www.ncbi.nlm.nih.gov/pubmed/29366703
http://dx.doi.org/10.1016/j.vaccine.2017.12.078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054558/
https://www.ncbi.nlm.nih.gov/pubmed/29366703
http://dx.doi.org/10.1016/j.vaccine.2017.12.078

Ejemplares similares